, Volume 5, Issue 3, pp 193–201 | Cite as

Neutrophil responses to platelet-activating factor

  • J. T. O'Flaherty
  • C. H. Miller
  • J. C. Lewis
  • R. L. Wykle
  • D. A. Bass
  • C. E. McCall
  • M. Waite
  • L. R. DeChatelet
Original Articles


1-O-Alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (i.e., platelet-activating factor) was prepared and confirmed to possess potent platelet aggregating activity. It was also potent in aggregating and degranulating rabbit and human neutrophils. When injected into rabbits, the lipid induced profound neutropenia, thrombocytopenia, and anaphylactic symptoms. The lyso derivative of this lipid, 1-O-alkyl-sn-glyceryl-3-phosphorylcholine, was inactive or several orders of magnitude weaker in inducing these responses. The acetylated lipid appears to be a potent stimulator of both platelets and neutrophils. Its anaphylactic-like toxicity may be related, at least in part, to its ability to aggregate or otherwise stimulate these cells.


Public Health Lipid Internal Medicine Neutropenia Thrombocytopenia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    O'Flaherty, J. T., P. R. Craddock, andH. S. Jacob. 1978. The effect of intravascular complement activation on granulocyte adhesiveness and distribution.Blood 51:731–739.Google Scholar
  2. 2.
    Craddock, P. R., D. H. Hammerschmidt, J. C. White, A. P. Dalmasso, andH. S. Jacob. 1977. Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyser cellophane membranes.J. Clin. Invest. 59:879–888.Google Scholar
  3. 3.
    O'Flaherty, J. T., D. L. Kreutzer, andP. A. Ward. 1977. Neutrophil aggregation and swelling induced by chemotactic agents.J. Immunol. 119:232–239.Google Scholar
  4. 4.
    O'Flaherty, J. T., S. Cousart, A. S. Lineberger, E. Bond, D. A. Bass, L. R. DeChatelet, E. S. Leake, andC. E. McCall. 1980. Phorbol myristate acetate: In vivo effects upon neutrophils, platelets, and lung.Am. J. Pathol. 101:79–92.Google Scholar
  5. 5.
    Silver, M. J., W. Hoch, J. J. Koscis, C. M. Ingerman, andJ. B. Smith. 1974, Arachidonic acid causes sudden death in rabbits.Science 183:1085–1087.Google Scholar
  6. 6.
    Willis, A. L. 1974. Isolation of a chemical trigger for thrombosis.Prostaglandins 5:1–23.Google Scholar
  7. 7.
    Pinckard, R. N., R. S. Farr, andD. J. Hanahan. 1979. Physiochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE sensitized basophils.J. Immunol. 123:1847–1857.Google Scholar
  8. 8.
    Demopoulos, C. A., R. N. Pinchard, andD. J. Hanahan. 1979. Platelet-activating factor: Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (A new class of lipid chemical mediators).J. Biol. Chem. 254:9355–9358.Google Scholar
  9. 9.
    Benveniste, J., M. Tence, P. Varenne, J. Bedault, C. Boullet, andJ. Polonsky. 1980. Semi-synthese et structure proposee du facteur activant les plaquettes (PAF): PAF-acether, un alkyl ether analogue de la lysophosphatidylcholine.C.R. Acad. Sci. Paris 289:1037–1040.Google Scholar
  10. 10.
    Hanahan, D. J., C. A. Demopoulos, J. Liehr, andR. N. Pinckard. 1980. Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine.J. Biol. Chem. 12:5514–5516.Google Scholar
  11. 11.
    Goetzl, E. J., C. K. Derian, A. I. Tauber, andF. H. Valone. 1980. Novel effects of 1-O-hexadecyl-2-acyl-sn-glycero-3-phosphorylcholine mediators on human leukocyte function: Delineation of the specific roles of the acyl substituted lipids.Biochem. Biophys. Res. Commun. 94:881–888.Google Scholar
  12. 12.
    McManus, L. M., D. J. Hanahan, C. A. Demopoulos, andR. N. Pinckard. 1980. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), as synthetic platelet-activating factor (PAF), in the rabbit.J. Immunol. 124:2919–2924.Google Scholar
  13. 13.
    Blank, M. L., F. Snyder, L. W. Byers, B. Brooks, andE. E. Muirhear. 1979. Anti-hypertensive activity of an alkyl ether analog of phosphatidylcholine.Biochem. Biophys. Res. Commun. 90:1194–1200.Google Scholar
  14. 14.
    Gupta, C. M., R. Radhabresham, andH. G. Khorana. 1977. Glycerophospholipid synthesis: Improved general method and new analogs containing photoactivable groups.Proc. Natl. Acad. Sci. U.S.A. 74:4315–4319.Google Scholar
  15. 15.
    Rouser, G., A. N. Siakotos, andS. Fleuscher. 1966. Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots.Lipids 1:85–86.Google Scholar
  16. 16.
    Lotner, G. Z., J. M. Lynch, S. J. Betz, andP. M. Henson. 1980. Human neutrophil-derived platelet activating factor.J. Immunol. 124:676–684.Google Scholar
  17. 17.
    O'Flaherty, J. T., H. J. Showell, E. L. Becker, andP. A. Ward. 1979. Neutrophil aggregation and degranulation: Effect of arachidonic acid.Am. J. Pathol. 95:435–444.Google Scholar
  18. 18.
    Showell. H. J., P. H. Naccache, R. I. Sha'afi, andE. L. Becker. 1977. The effects of extracellular K+, Na+, and Ca2+ on lysosomal enzyme secretion from polymorphonuclear leukocytes.J. Immunol. 119:804–810.Google Scholar

Copyright information

© Plenum Publishing Corporation 1981

Authors and Affiliations

  • J. T. O'Flaherty
    • 1
  • C. H. Miller
    • 2
  • J. C. Lewis
    • 3
  • R. L. Wykle
    • 4
  • D. A. Bass
    • 1
  • C. E. McCall
    • 1
  • M. Waite
    • 4
  • L. R. DeChatelet
    • 4
  1. 1.Department of MedicineBowman Gray School of MedicineWinston-Salem
  2. 2.Department of Chemistry and PhysicsSalem CollegeWinston-Salem
  3. 3.Department of PathologyBowman Gray School of MedicineWinston-Salem
  4. 4.Department of BiochemistryBowman Gray School of MedicineWinston-Salem

Personalised recommendations